These findings provide a substantial contribution to the already compelling evidence that plasma PAI-1 is an important clinical predictor of vascular stiffness, hypertension, and diastolic dysfunction, especially in individuals with obesity and diabetes. Here, SERPINE1 is linked to diabetes mellitus.